Report Overview
Povidone (polyvinylpyrrolidone, PVP) is a water-soluble polymer compound made from the monomer N-vinylpyrrolidone. According to product requirements, PVP can be divided into four types: industrial grade, cosmetic grade, food grade and pharmaceutical grade. It is used in the pharmaceutical industry as a synthetic polymer vehicle for dispersing and suspending drugs.
The global Pharmaceutical Grade Povidones market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
Analytic Insights Hub ' newest research report, the “Pharmaceutical Grade Povidones Industry Forecast” looks at past sales and reviews total world Pharmaceutical Grade Povidones sales in 2023, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade Povidones sales for 2024 through 2030. With Pharmaceutical Grade Povidones sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade Povidones industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade Povidones landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade Povidones portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Grade Povidones market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade Povidones and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade Povidones.
United States market for Pharmaceutical Grade Povidones is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pharmaceutical Grade Povidones is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pharmaceutical Grade Povidones is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pharmaceutical Grade Povidones players cover BASF, Ashland, Boai NKY Medical Holdings, DKS, JRS Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade Povidones market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Povidone K30
Povidone K90
Povidone K15
Others
Segmentation by Application:
Oral Solid Formulation
Oral Liquid Formulation
Ophthalmic Drugs
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BASF
Ashland
Boai NKY Medical Holdings
DKS
JRS Pharma
JH Nanhang Life Sciences
Cnsg Anhui Hongsifang
Sichuan Tianhua
Huangshan Bonsun Pharmaceutical
Jiaozuo Zhongwei Special Products Pharmaceutical
Hangzhou Motto Science&Technology
Shanghai Yuking Water Soluble Material Technology
Anhui Sunhere Pharmaceutical Excipients
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceutical Grade Povidones market?
What factors are driving Pharmaceutical Grade Povidones market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Grade Povidones market opportunities vary by end market size?
How does Pharmaceutical Grade Povidones break out by Type, by Application?
Table Of Contents
Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2017-2029)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Pharmaceutical Grade Povidones Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Pharmaceutical Grade Povidones Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Pharmaceutical Grade Povidones Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by region)
5 Global Pharmaceutical Grade Povidones Market-Segmentation by Type
5.1 Type 1
5.2 Type 2
5.3 Type 3
6 Global Pharmaceutical Grade Povidones Market-Segmentation by Application
6.1 Application 1
6.2 Application 2
6.3 Application 3
7 Global Pharmaceutical Grade Povidones Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence A Company Profiles
8.1 Company 1
8.1.1 Company 1 Profile
8.1.2 Company 1 Sales, Growth Rate and Global Market Share from 2017-2023
8.1.3 Company 1 Product/Solution Launches and Enhancements Analysis
8.1.4 Company 1 Business Overview/Recent Development/Acquisitions
8.2 Company 2
8.2.1 Company 2 Profile
8.2.2 Company 2 Sales, Growth Rate and Global Market Share from 2017-2023
8.2.3 Company 2 Product/Solution Launches and Enhancements Analysis
8.2.4 Company 2 Business Overview/Recent Development/Acquisitions
8.3 Company 3
8.3.1 Company 3 Profile
8.3.2 Company 3 Sales, Growth Rate and Global Market Share from 2017-2023
8.3.3 Company 3 Product/Solution Launches and Enhancements Analysis
8.3.4 Company 3 Business Overview/Recent Development/Acquisitions
8.4 Company 4
8.4.1 Company 4 Profile
8.4.2 Company 4 Sales, Growth Rate and Global Market Share from 2017-2023
8.4.3 Company 4 Product/Solution Launches and Enhancements Analysis
8.4.4 Company 4 Business Overview/Recent Development/Acquisitions
8.5 Company 5
8.5.1 Company 5 Profile
8.5.2 Company 5 Sales, Growth Rate and Global Market Share from 2017-2023
8.5.3 Company 5 Product/Solution Launches and Enhancements Analysis
8.5.4 Company 5 Business Overview/Recent Development/Acquisitions
8.6 Company 6
8.6.1 Company 6 Profile
8.6.2 Company 6 Sales, Growth Rate and Global Market Share from 2017-2023
8.6.3 Company 6 Product/Solution Launches and Enhancements Analysis
8.6.4 Company 6 Business Overview/Recent Development/Acquisitions
8.7 Company 7
8.7.1 Company 7 Profile
8.7.2 Company 7 Sales, Growth Rate and Global Market Share from 2017-2023
8.7.3 Company 7 Product/Solution Launches and Enhancements Analysis
8.7.4 Company 7 Business Overview/Recent Development/Acquisitions
8.8 Company 8
8.8.1 Company 8 Profile
8.8.2 Company 8 Sales, Growth Rate and Global Market Share from 2017-2023
8.8.3 Company 8 Product/Solution Launches and Enhancements Analysis
8.8.4 Company 8 Business Overview/Recent Development/Acquisitions
8.9 Company 9
8.9.1 Company 9 Profile
8.9.2 Company 9 Sales, Growth Rate and Global Market Share from 2017-2023
8.9.3 Company 9 Product/Solution Launches and Enhancements Analysis
8.9.4 Company 9 Business Overview/Recent Development/Acquisitions
8.10 Company 10
8.10.1 Company 10 Profile
8.10.2 Company 10 Sales, Growth Rate and Global Market Share from 2017-2023
8.10.3 Company 10 Product/Solution Launches and Enhancements Analysis
8.10.4 Company 10 Business Overview/Recent Development/Acquisitions
8.11 Company 11
8.11.1 Company 11 Profile
8.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2017-2023
8.11.3 Company 11 Product/Solution Launches and Enhancements Analysis
8.11.4 Company 11 Business Overview/Recent Development/Acquisitions
8.12 Company 12
8.12.1 Company 12 Profile
8.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2017-2023
8.12.3 Company 12 Product/Solution Launches and Enhancements Analysis
8.12.4 Company 12 Business Overview/Recent Development/Acquisitions
8.13 Company 13
8.13.1 Company 13 Profile
8.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2017-2023
8.13.3 Company 13 Product/Solution Launches and Enhancements Analysis
8.13.4 Company 13 Business Overview/Recent Development/Acquisitions
8.14 Company 14
8.14.1 Company 14 Profile
8.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2017-2023
8.14.3 Company 14 Product/Solution Launches and Enhancements Analysis
8.14.4 Company 14 Business Overview/Recent Development/Acquisitions
8.15 Company 15
8.15.1 Company 15 Profile
8.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2017-2023
8.15.3 Company 15 Product/Solution Launches and Enhancements Analysis
8.15.4 Company 15 Business Overview/Recent Development/Acquisitions
9 Global Pharmaceutical Grade Povidones Market-Segmentation by Geography
10 North America
10.1 North America Pharmaceutical Grade Povidones Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
10.2 North America Pharmaceutical Grade Povidones Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
10.3 North America Pharmaceutical Grade Povidones Production Analysis from 2017-2023
10.4 North America Pharmaceutical Grade Povidones Consumption Analysis from 2017-2023
10.5 North America Pharmaceutical Grade Povidones Import and Export from 2017-2023
10.6 North America Pharmaceutical Grade Povidones Value, Production and Market Share by Type (2017-2023)
10.7 North America Pharmaceutical Grade Povidones Consumption, Value and Market Share by Application (2017-2023)
10.8 North America Pharmaceutical Grade Povidones by Country (United States, Canada)
10.8.1 North America Pharmaceutical Grade Povidones Sales by Country (2017-2023)
10.8.2 North America Pharmaceutical Grade Povidones Consumption Value by Country (2017-2023)
10.9 North America Pharmaceutical Grade Povidones Market PEST Analysis
11 Europe
11.1 Europe Pharmaceutical Grade Povidones Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
11.2 Europe Pharmaceutical Grade Povidones Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
11.3 Europe Pharmaceutical Grade Povidones Production Analysis from 2017-2023
11.4 Europe Pharmaceutical Grade Povidones Consumption Analysis from 2017-2023
11.5 Europe Pharmaceutical Grade Povidones Import and Export from 2017-2023
11.6 Europe Pharmaceutical Grade Povidones Value, Production and Market Share by Type (2017-2023)
11.7 Europe Pharmaceutical Grade Povidones Consumption, Value and Market Share by Application (2017-2023)
11.8 Europe Pharmaceutical Grade Povidones by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Pharmaceutical Grade Povidones Sales by Country (2017-2023)
11.8.2 Europe Pharmaceutical Grade Povidones Consumption Value by Country (2017-2023)
11.9 Europe Pharmaceutical Grade Povidones Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Pharmaceutical Grade Povidones Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
12.2 Asia-Pacific Pharmaceutical Grade Povidones Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
12.3 Asia-Pacific Pharmaceutical Grade Povidones Production Analysis from 2017-2023
12.4 Asia-Pacific Pharmaceutical Grade Povidones Consumption Analysis from 2017-2023
12.5 Asia-Pacific Pharmaceutical Grade Povidones Import and Export from 2017-2023
12.6 Asia-Pacific Pharmaceutical Grade Povidones Value, Production and Market Share by Type (2017-2023)
12.7 Asia-Pacific Pharmaceutical Grade Povidones Consumption, Value and Market Share by Application (2017-2023)
12.8 Asia-Pacific Pharmaceutical Grade Povidones by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Pharmaceutical Grade Povidones Sales by Country (2017-2023)
12.8.2 Asia-Pacific Pharmaceutical Grade Povidones Consumption Value by Country (2017-2023)
12.9 Asia-Pacific Pharmaceutical Grade Povidones Market PEST Analysis
13 Latin America
13.1 Latin America Pharmaceutical Grade Povidones Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
13.2 Latin America Pharmaceutical Grade Povidones Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
13.3 Latin America Pharmaceutical Grade Povidones Production Analysis from 2017-2023
13.4 Latin America Pharmaceutical Grade Povidones Consumption Analysis from 2017-2023
13.5 Latin America Pharmaceutical Grade Povidones Import and Export from 2017-2023
13.6 Latin America Pharmaceutical Grade Povidones Value, Production and Market Share by Type (2017-2023)
13.7 Latin America Pharmaceutical Grade Povidones Consumption, Value and Market Share by Application (2017-2023)
13.8 Latin America Pharmaceutical Grade Povidones by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Pharmaceutical Grade Povidones Sales by Country (2017-2023)
13.8.2 Latin America Pharmaceutical Grade Povidones Consumption Value by Country (2017-2023)
13.9 Latin America Pharmaceutical Grade Povidones Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Pharmaceutical Grade Povidones Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
14.2 Middle East & Africa Pharmaceutical Grade Povidones Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
14.3 Middle East & Africa Pharmaceutical Grade Povidones Production Analysis from 2017-2023
14.4 Middle East & Africa Pharmaceutical Grade Povidones Consumption Analysis from 2017-2023
14.5 Middle East & Africa Pharmaceutical Grade Povidones Import and Export from 2017-2023
14.6 Middle East & Africa Pharmaceutical Grade Povidones Value, Production and Market Share by Type (2017-2023)
14.7 Middle East & Africa Pharmaceutical Grade Povidones Consumption, Value and Market Share by Application (2017-2023)
14.8 Middle East & Africa Pharmaceutical Grade Povidones by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Pharmaceutical Grade Povidones Sales by Country (2017-2023)
14.8.2 Middle East & Africa Pharmaceutical Grade Povidones Consumption Value by Country (2017-2023)
14.9 Middle East & Africa Pharmaceutical Grade Povidones Market PEST Analysis
15 Future Forecast of the Global Pharmaceutical Grade Povidones Market from 2023-2029
15.1 Future Forecast of the Global Pharmaceutical Grade Povidones Market from 2023-2029 Segment by Region
15.2 Global Pharmaceutical Grade Povidones Production and Growth Rate Forecast by Type (2023-2029)
15.3 Global Pharmaceutical Grade Povidones Consumption and Growth Rate Forecast by Application (2023-2029)
16 Appendix
16.1 Methodology
16.2 Research Data Source